
1. transplantation. 1997 sep 15;64(5):786-8.

hepatitis g virus coinfection hepatitis c virus-infected liver transplant
recipients.

vargas he(1), laskus t, radkowski m, poutous a, wang lf, lee r, dodson f,
gayowski t, singh n, marino ir, fung jj, zhang-keck zy, kim jp, rakela j.

author information: 
(1)division gastroenterology hepatology, university pittsburgh,
pennsylvania 15213-2582, usa.

background: study, determined prevalence hepatitis g virus
(hgv) infection end-stage hepatitis c virus (hcv)-related liver disease and
examined influence hgv coinfection outcome liver
transplantation.
methods: hgv detected reverse transcriptase-polymerase chain reaction 
southern blotting sera drawn 159 patients known hcv
infected transplantation. patients followed mean 28.4
months transplantation.
results: forty-one (25.3%) patients hgv positive prevalence hgv
infection similar different hcv genotypes. hgv-positive and
-negative groups similar survival, recurrence rates, inflammatory activity
scores, degree fibrosis time recurrence.
conclusion: infection hgv common end-stage hcv-infected patients
presenting liver transplantation. influences neither outcome liver 
transplantation recurrence hepatitis graft.

doi: 10.1097/00007890-199709150-00025 
pmid: 9311724  [indexed medline]

